Hematoma is quite a common complication of femoral arterial catheterization. However, to the best of our knowledge, there have been no previous studies regarding deep vein thrombosis (DVT) caused by compression of a vein due to a hematoma. We report a case of a hematoma developing after femoral arterial catheterization and causing extensive symptomatic DVT. A 59-year-old male was seen in our Emergency Department with right lower leg swelling 15 days after coronary stent implantation performed using right femoral artery access. Computed tomographic (CT) scanning revealed a large hematoma (45 mm in its longest diameter) compressing the common femoral vein and with DVT from the right external iliac vein to the popliteal vein. Due to the extensive DVT involvement, we decided to release the compressed common femoral vein by surgical evacuation of the large hematoma. However, even following evacuation of the hematoma, as the DVT did not resolve soon, further mechanical thrombectomy and catheter-directed thrombolysis were performed. Angiography then showed nearly resolved DVT, and the leg swelling was improved. The patient was discharged with the anticoagulation medication, warfarin.
INTRODUCTION
Vascular complications related to arterial catheterization occur in 1.7% to 8.4% of the percutaneous coronary interventions performed using femoral access. [1] [2] [3] [4] [5] Most of the reported complications are bleeding, hematoma, and pseudoaneurysm. Deep-vein thrombosis (DVT) as a complication of femoral arterial catheterization has also been reported with an infrequent incidence of 0.05% to 2.4%, 6, 7 and most of the reported cases were considered to have been caused by prolonged manual compression after the removal of sheath.
We report a case of hematoma related to femoral arterial catheterization causing compressive venous obstruction and thrombosis. In this case, surgical evacuation of the hematoma, mechanical thrombectomy, and catheter-directed thrombolysis were required in order to improve the venous thrombosis.
CASE
A 59-year-old male patient was seen in our Emergency Department with right, lower extremity swelling and a right inguinal mass lesion. Approximately 15 days before being seen in the Emergency Department, the patient had undergone elective coronary stenting (Xience Prime ® , Abbott Vascular, Ireland; 4.0×18 mm) in the proximal right coronary artery and performed using right femoral arterial catheterization with a 7Fr. Sheath. The procedure was completed without any complications. A vascular closure device (PercloseProglide ® , Abbott Vascular, Ireland; 6Fr.) was used for management of the puncture site. The patient was discharged with 100 mg of aspirin and 75 mg of clopidogrel one day following the stent. Fifteen days after his discharge, the patient revisited the Emergency Department due to aggravated, right lower extremity swelling and a mass in the puncture site.
Distal arterial pulsation in the dorsalis pedis and the posterior tibial arteries was intact, and the patient did not complain of any other symptoms such as chest pain, dyspnea or dizziness. Hemoglobin was 13.9 g/dL which was not decreased from that seen at discharge. Other laboratory data were unremarkable (WBC 8,500/mm (Fig. 1B) . Pulmonary embolism CT showed no evidence of pulmonary thrombo-embolism. Anticoagulation with intravenous infusion of unfractionated heparin (target aPTT: 50.0-75.0 sec) was administered immediately. After 24-hours of heparin, infusion venography via the popliteal vein was performed. There was complete obstruction of the common femoral vein (CFV) due to external compression from the hematoma (Fig. 1C ). Dilatation using a balloon 10-mm in diameter for CFV occlusion was unsuccessful due to the immediate recoil (Fig. 1D) .
On the next day, surgical hematoma evacuation for release of external compression was successfully performed. On the surgical field, adhesive hematoma mixed with inflammation and fat tissue rather than pure hematoma, was observed. The pathology findings showed fibroblastic proliferation with hemorrhage and a heterotopic, chondro-osseous lesion, thus suggesting ossified hematoma.
Two days following the evacuation, the surgical site oozed with pus. Distal edema aggravated and leukocytosis (WBC 13,100/mm 3 ) developed with elevated C-reactive protein (4.55 mg/dL). Antibiotics (cefazolin 2 gram per 8 hours) were administered in order to address the risk of infection. After administration of the antibiotics, the surgical site improved and inflammatory markers such as the leukocyte count as well as the C-reactive protein value normalized. However, despite the improving infection signs at the surgical site, distal edema still remained.
Even after seven days of continuous anticoagulation with intravenous heparinization, the patient's right leg swelling did not improve. CT angiography was then performed to evaluate the response to the anticoagulation. Multiple, small hematomas with indistinct delineation around the right CFV, remained, although the main hematoma was resolved after surgical evacuation, and compression of the right CFV was partially relieved (Fig. 2A) . DVT in the EIV was resolved, although it still remained from the superficial femoral vein (SFV) to the calf veins (Fig. 2B-D) . Transluminal mechanical thrombectomy with heparinization via a right popliteal vein approach was then done, and extensive thrombi were extracted (Fig. 3A ). An immediate, follow-up angiogram showed extensive remaining thrombosis which had rapidly developed (Fig. 3B) . Additional, catheter-directed thrombolysis with urokinase was then performed (4,400 units/kg intravenously during the initial 10 minutes and then 2,200 units/kg per hour for 12 hours). The final, follow-up angiogram showed much resolved thrombi (Fig. 3C) , after which the edema resolved gradually and the patient was discharged and instructed to take aspirin, 
DISCUSSION
Vascular complications, such as bleeding, hematoma, and pseudoaneurysm, related to the femoral arterial catheterization, occur in 1.7% to 8.4% of patients. [1] [2] [3] [4] [5] Among these complications, major bleeding has been associated with increased mortality. Doyle et al. found that major femoral bleeding and blood transfusions were associated with a significant increase in the 30-day mortality rate. 3 In other studies, association of one-year mortality to major bleeding has been reported. Applegate et al. reported that vascular complication is an independent predictor of non-fatal myocardial infarction or death by one year, if accompanied by thrombolysis in myocardial infarction major and minor bleeding. 5 Romaguera et al. reported that vascular complications with decreased hematocrit of more than 9.2% caused an increased risk for death by one year. 4 Risk factors for femoral bleeding after catheterization include periprocedural use of heparin or fibrinolytic therapy, repeated procedures, peripheral artery disease, advanced patient age, obesity, duration of time that the sheath remains in place particularly if >15 hours, the use of an intra-aortic balloon pump, larger arterial sheath size, and cannulation of the superficial femoral artery. 8, 9 Vascular closure devices, bivalirudin, a mechanical clamp, and a radial approach can, therefore, be the optimal strategies for reducing hemorrhagic complications. Although meta-analyses regarding the vascular closure devices have reported unchanged or even an increased bleeding risk, 10,11 a large amount of recent data from the National Cardiovascular Data Registry showed a decreased bleeding risk, particularly among the patients at greatest risk for bleeding. 12 The use of direct thrombin inhibitors such as bivalirudin rather than heparin and a glycoprotein 2b/3a receptor blocker are associated with a lower risk of hemorrhagic complications. 13, 14 A mechanical clamp reduced the frequency of ultrasounddefined vascular complications by 63 percent in one trial. 15 Despite the absence of the risk factors listed above, and even with the usage of a vascular closure device, hematoma causing compressive DVT occurred in our patient. Therefore, a learning curve in order to be familiar with and be able to skillfully use a closure device, is necessary. Therefore, even with the use of a closure device, additional mechanical compression and intense surveillance are required.
The incidence of DVT as a complication of femoral arterial catheterization has been reported as occurring in 0.05% to 2.4% of patients. 6, 7 Filis et al. reported five cases of DVT in 10,450 patients who underwent femoral arterial puncture for cardiac catheterization. 7 In all five of these patients, DVT was detected after the discharge during the antiplatelet treatment and was successfully resolved using conservative management. Post-catheterization manual compression was the obvious cause for DVT in all of these cases. Zahn et al. prospectively examined duplex sonography for 450 consecutive patients undergoing diagnostic cardiac catheterization. 6 Partially occluding venous thrombi were detected in 11 patients, and only one patient had extravenous compression. Only two patients had clinical symptoms of DVT, such as edema, and no one developed symptoms of pulmonary embolism. There are also some case reports regarding DVT caused by manual compression following femoral arterial catheterization. 16, 17 Concurrent pulmonary embolism and stroke via the foramen ovale have even been reported, 18 and there are only two reported cases of DVT associated with extravenous compression following cardiac catheterization. 19, 20 Because both of these cases resulted from pseudoaneurysm, ours is the first case report of DVT associated with extravenous compression from hematoma following femoral arterial catheterization. Post-thrombotic syndrome (PTS) consisting of leg pain, edema, venous ectasia, and skin induration with ulceration, occurs in 20% to 50% of chronic DVT patients. PTS has a significant impact on their disease-specific quality of life. 21 Compared to anticoagulation alone, catheter-directed thrombolysis (CDT) successfully improved their quality of life, and this effect was correlated with successful lysis on phlebography. 22 The safety and successful long-term patency of CDT have been reported. 23, 24 In our patient, hematoma evacuation and transluminal mechanical thrombectomy failed to resolve the DVT, although CDT successfully improved the DVT. A further, randomized study to determine the efficacy of early CDT in DVT is currently in progress. 25 
